Efficacy of Vedolizumab for Inflammatory Bowel Disease in the Setting of DiGeorge Syndrome

Journal article

Open access

Peer reviewed

Eve Thau, Hillary Aaron Moore, Philip Stein and Kathy Chen

Journal of pediatric gastroenterology and nutrition, v 68(5), pp E88-E88

01 May 2019

PMID: 30889127

Files and links (1)

url

https://doi.org/10.1097/mpg.0000000000002322View

Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze), Open

Gastroenterology & Hepatology

Life Sciences & Biomedicine

Nutrition & Dietetics

Pediatrics

Science & Technology

7 Record Views

2 citations in Scopus

Title: Efficacy of Vedolizumab for Inflammatory Bowel Disease in the Setting of DiGeorge Syndrome
Creators: Eve Thau - St. Christopher's Hospital for Children
Hillary Aaron Moore - Drexel Univ, St Christophers Hosp Children, Coll Med, Dept Pediat,Sect Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA
Philip Stein - Drexel University
Kathy Chen - Drexel University
Publication Details: Journal of pediatric gastroenterology and nutrition, v 68(5), pp E88-E88
Publisher: Lippincott Williams & Wilkins
Number of pages: 1
Resource Type: Journal article
Language: English
Academic Unit: Pediatrics
Web of Science ID: WOS:000480691800007
Scopus ID: 2-s2.0-85065343487
Other Identifier: 991019167744104721

This publication has contributed to the advancement of the following goals:

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas: Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics